The company specializes in providing oncology drug discovery information and offers genomic data and analysis tools to researchers, enabling them to validate their biomarker and gene target discoveries. Compendia Bioscience's dedication lies in utilizing the vast global collection of cancer genomic data to make a tangible impact on patient care, with a focus on improving cancer diagnostics and treatments. By empowering researchers with valuable insights and resources, the company aims to drive advancements in precision medicine and contribute to the fight against cancer.